Associated Papers
Clinical Features and Genetic Characteristics of XLID Patients With KDM5C Gene Mutations: Insights on Phenotype-Genotype Correlations From 175 Previous Cases and Identification of a Novel Variant.
Ghasemi MR et al.
Molecular Genetics & Genomic Medicine, 2025
39835750 (PubMed )
Supplement: MGG3-13-e70057-s001.xlsx › stop_gain
Molecular and cellular events linking variants in the histone demethylase KDM5C to the intellectual disability disorder Claes-Jensen syndrome.
Hatch HAM et al.
The Febs Journal, 2022
A genome-wide DNA methylation signature for SETD1B-related syndrome.
Krzyzewska IM et al.
Clinical Epigenetics, 2019
31685013 (PubMed )
Supplement: 13148_2019_749_MOESM5_ESM.xlsx › Sheet1
Peripheral blood epi-signature of Claes-Jensen syndrome enables sensitive and specific identification of patients and healthy carriers with pathogenic mutations in KDM5C.
Schenkel LC et al.
Clinical Epigenetics, 2018
KDM5C mutational screening among males with intellectual disability suggestive of X-Linked inheritance and review of the literature.
Gonçalves TF et al.
European Journal of Medical Genetics, 2014
Novel human pathological mutations. Gene symbol: JARID1C. Disease: mental retardation, X-linked.
Abidi F et al.
Human Genetics, 2009
Novel human pathological mutations. Gene symbol: JARID1C. Disease: mental retardation, X-linked.
Abidi F et al.
Human Genetics, 2009
Novel human pathological mutations. Gene symbol: JARID1C. Disease: mental retardation, X-linked.
Abidi F et al.
Human Genetics, 2009
Mutations in JARID1C are associated with X-linked mental retardation, short stature and hyperreflexia.
Abidi FE et al.
Journal of Medical Genetics, 2008
Select a paper to view details